Alkem laboratories boosts Enzene stake, contests tax order

Alkem Laboratories Limited acquired 6,402,018 equity shares of its subsidiary, Enzene Biosciences Limited ("Enzene"), for a total of INR 2,999,985,634.80. These "rights shares" were allotted to Alkem on December 26, 2025, increasing Alkem's shareholding in Enzene to 99.61% of its equity share capital. Enzene, incorporated in 2006, specializes in biosimilar and novel biologic research, development, and manufacturing, reporting a turnover of INR 363.62 crores for FY 2024-2025. This acquisition aims to meet Enzene's capital expenditure and working capital needs.

Separately, Alkem Laboratories disclosed receiving a tax order from the state tax officer, Thrippunithura Ernakulam, Kerala, on December 24, 2025. The order, relating to the period FY 2021-22, demands GST of Rs. 205,095 along with a penalty of Rs. 41,019 and applicable interest of Rs. 135,733 under the IGST Act, 2017, primarily for alleged excess availment of ITC.

Alkem Laboratories stated it does not agree with the demand and plans to contest it, confirming that the order has no material impact on the company's financial, operational, or other activities.